No elevated risk for depression, anxiety or suicidality with secukinumab in a pooled analysis of data from 10 clinical studies in moderate-to-severe plaque psoriasis.
Br J Dermatol
; 178(2): e105-e107, 2018 02.
Article
in En
| MEDLINE
| ID: mdl-28991372
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Psoriasis
/
Depressive Disorder
/
Dermatologic Agents
/
Suicidal Ideation
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
/
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
Br J Dermatol
Year:
2018
Document type:
Article
Affiliation country:
Country of publication: